In a 2-year study, we examined bone mass and calcium metabolism in 36 elderly women with moderate osteoporosis. The study period comprised 1 year of observation, during which the women received no treatment affecting calcium metabolism, and 1 year of treatment, during which all participants received
β¦ LIBER β¦
Salmon calcitonin in the therapy of corticoid-induced osteoporosis
β Scribed by J. -D. Ringe; D. Welzel
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 590 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Rectal salmon calcitonin for the treatme
β
Kirsten Overgaard; Marc Allan Hansen; Karen-Lisbeth Dirksen; Claus Christiansen
π
Article
π
1992
π
Springer
π
English
β 530 KB
Different therapeutic regimens of intran
β
G. AkyΓΌz; N. DoΗ΅an; Γ. Kayban
π
Article
π
1996
π
Springer-Verlag
π
English
β 134 KB
Osteoporosis in men and effectiveness of
β
Alp Γetin; YeΓ§im GΓΆkΓ§e Kutsal; Reyhan Γeliker; Macit AkyΓΌrek; Nurten Renda; Osma
π
Article
π
1996
π
Springer-Verlag
π
English
β 129 KB
Salmon calcitonin (Miacalcic) nasal spra
β
C. Gennari
π
Article
π
1989
π
Springer
π
English
β 395 KB
Growth hormone with and without salmon c
β
S. Gonnelli; C. Cepollaro; A. Montagnani; M S. Campagna; M B. Franci; C. Gennari
π
Article
π
1996
π
Springer-Verlag
π
English
β 120 KB
Estimation of the effect of salmon calci
β
N. Munk Nielsen; P. Recke; M. A. Hansen; K. Overgaard; C. Christiansen
π
Article
π
1994
π
Springer
π
English
β 357 KB
We reviewed data on 42 postmenopausal women with established osteoporosis (forearm fracture or a low bone mass) who had been randomly treated for 1 year with either rectal salmon calcitonin (sCT), 100 IU daily (n = 25) or nasal sCT, 200 IU daily (n = 17) applying an estimation algorithm for bone los